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Volume 59, Number 6S Abstracts 7SCEA alone was performed in 581 symptomatic patients
(32%) and in 1233 asymptomatic patients (68%). Stroke/
death/MI was 4.5% (2.8%/0.5%/1.2%) for symptomatic
patients and 4.0% (2.4%/0.4%/1.1%) for asymptomatic pa-
tients. CEA and coronary artery bypass grafting (CABG)
was performed in 155 patients (98.7% asymptomatic),
S/D/MI of 11.1% (3.9%/5.8/%1.3%). Of 332 patients,
CAS was performed in 119 symptomatic patients (36%)
and in 213 asymptomatic patients (64%), with 255 (77%)
treated as part of a Food and Drug Administration-
approved trial. S/D/MI was 9.2% (4.2%/4.2%/0.8%) for
symptomatic patients and 5.2% (3.3%/1.4%/0.4%) for
asymptomatic patients. Symptomatic CAS patients treated
in a clinical trial (n ¼ 64) had two eventsdS/D/MI of
3.1% (3.1%/0%/0%). Symptomatic patients treated outside
a clinical trial (n ¼ 55) had nine eventsdS/D/MI of
16.4% (5.5%/9%/1/1.8%).
Conclusions: (1). The prospectively collected, inde-
pendently veriﬁed S/D/MI rates for all CEA and CAS
performed within a clinical trial were equivalent to the
CREST results. (2) S/D/MI for CAS in symptomatic
patients was signiﬁcantly higher than CEA (9.2% vs
4.5%; P ¼ .034). (3). S/D/MI for CAS in symptomatic
patients within a clinical trial was equivalent to CEA
(3.1% vs 4.5%; P ¼ .759). Symptomatic CAS patients
who did not qualify for a clinical trial had a ﬁve times
increased risk of S/D/MI of 16.4%. (4) S/D/MI for
CAS in asymptomatic patients was equivalent to CEA
(5.2% vs 4.0%; P ¼ .42). (5). CEA/CABG in asymptom-
atic patients is associated with a three-times increased risk
of S/D/MI compared with patients undergoing CEA for
asymptomatic disease.
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Kinematics Effectively Delineate Accomplished Users
of Endovascular Robotics Using a Physical Training
Model
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Bismuth1. 1The Methodist DeBakey Heart & Vascular
Center, Houston, Tex; 2Rice University, Houston, Tex
Objectives: Endovascular robotics systems, now
approved for clinical use in the United States and Europe,
are seeing rapid growth in interest. Determining who has
sufﬁcient expertise for safe and effective clinical use remains
elusive. Our aim was to analyze performance on a robotic
platform to determine what deﬁnes an expert user.
Methods: Over three sessions, 20 subjects with a
range of endovascular expertise and endovascular robotic
experience (novices <2 hours to moderate-extensive expe-
rience with >20 hours), performed four tasks on a training
model. All participants completed a 2-hour training session
on the robot by a certiﬁed instructor. Electromagnetic
tracking was used to capture and analyze catheter tip mo-
tion. Motion analysis was based on derivations of speed
and position, including spectral arc length and totalnumber of submovements (inversely proportional to proﬁ-
ciency of motion) and duration of submovements (directly
proportional to proﬁciency).
Results: There was no signiﬁcant difference in
completion times between novices and experienced users.
The experienced users had more efﬁcient motion and per-
formed more consistently. Users with >20 hours per-
formed signiﬁcantly better than those new to the system,
independent of standard endovascular experience (Table).
Conclusions: Expertise in performance of traditional
manual endovascular interventions does not translate to
performance on the endovascular robot. Efﬁciency of cath-
eter movement and consistency of performance may help
identify users who are sufﬁciently trained for safe clinical
use of the system. This work will help identify the learning
curve and speciﬁc movements that translate to expert ro-
botic navigation.
Table. Motion metrics for robotic task performance
Competent Noncompetent PSpectral arc length, mean mm 18.18 28.82 <.0001
Submovements
Mean number per sec 0.415 0.642 <.0001
Mean duration, sec 3.27 1.77 <.0001Author Disclosures: J. Bismuth: Hansen Medical,
consulting fees or other remuneration (payment); C.
Duran: Nothing to disclose; S. Estrada: Nothing to
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Objectives: Aneurysm related complications can result
in lost of a functioning autogenous arteriovenous ﬁstula
(aAVF). We reviewed our results with aneurysmorrhaphy
to preserve and extend the aAVF use span.
Methods: Over the past 6-year period, we retrospec-
tively reviewed the surgical outcome in patients with an
aAVF who presented with aneurysm-related bleeding,
infection, and/or skin erosion. Of 50 patients who were
identiﬁed, 36 (72%) underwent aneurysmorrhaphy. The
operation involves resecting the redundant aneurysm wall
along with compromised skin and primarily remodeling
the remaining vein to create a conduit 6 to 8mm in diameter.
Results: Thirty-four of 36 (94%) complicated AVFs
were successfully repaired primarily with aneurysmorrha-
phy. Median patient age was 65.5 years (range, 29-88
years). Median AVF age was 61.5 months (range, 12-136
months). Median patient follow-up was 15.5 months
(range, 1-76 months). Seventy-ﬁve percent of patients
had at least 9 months of follow-up, and 25% had at least
28 months. Primary patency was 67% and 57%, assisted pri-
mary patency was 85% and 80%, and secondary patency was
89% and 89% at 1 and 2 years, respectively. Local regional
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Conclusions: This is the largest number of reported
case series in patients with aAVF aneurysmal-related com-
plications who underwent aneurysmorrhaphy. Surgical
aneurysmorrhaphy is a highly successful repair that will pre-
serve the native AVF and extend its functional life with very
low complications. Diligence has to be taken to evaluate
and treat for central venous stenosis to maintain use of
the AVF and prevent recurrence of further aneurysms.
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Objectives: Avoidance of stents within the venous cir-
cuit of an arteriovenous (AV) access is well accepted. The
challenge facing the access surgeon in caring for the patient
with a failing hemodialysis access is to determine the
optimal time to create a new access. We reviewed our
data, with our “stent-aversion” policy in an effort to answer
this question.
Methods: Data from consecutive patients treated in
our facility from May 2012 to September 2013 were
reviewed. Time to ﬁrst AV access failure was measured as
the time between the date of the procedure and failure
or last follow-up. The proportion of AV access failure was
compared in the two groups using the c2 test. A Cox pro-
portional hazards regression model was used to evaluate
the risk of failure by group.
Results: A total of 170 patients had complete data
available for review. Ninety-two patients (54%) were
treated with angioplasty alone, and 78 (46%) underwent
angioplasty and stent placement. Patency was continually
evaluated, and all patients underwent a clinical examina-
tion at 90 days with ﬁstulography used as needed. Average
age was 66.9 years (standard deviation, 13.9), with 51%
males. Median follow-up time was 8.5 months. The overall
proportion of failure was 19%: 12% in the angioplasty
group vs 27% in the stent group (P ¼ .013. Results from
Cox regression showed that patients in the stent group
had signiﬁcantly higher risk of failure (hazard ratio, 2.47;
95% conﬁdence interval, 1.15-5.33; P ¼ .021). Higher
risk of failure was also signiﬁcantly associated with
increased number of comorbidities (hazard ratio, 1.40;
P ¼ .020). Kaplan Meier results showed that the 9-month
failure rate was 12% in angioplasty group vs 33% in the
stent group.
Conclusions: This review conﬁrms the inferiority of
stents in the management of the failing hemodialysis access.
We advocate for the planning of new access creation at the
time a stent is placed into the AV access circuit to reduce
the need for further interventions.
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Objectives: The Society for Vascular Surgery (SVS)
recommends annual imaging after endovascular aneurysm
repair (EVAR). We sought to describe adherence to these
surveillance guidelines and determine the association be-
tween adherence and long-term outcomes.
Methods: We analyzed fee-for-service Medicare
claims for patients receiving EVAR from 2002 to 2005,
collecting all relevant postoperative images through 2011.
Allowing for a grace period of 3 months, we deﬁned com-
plete surveillance as at least one CT or ultrasound assess-
ment every 15 months after EVAR. Outcomes included
all-cause mortality, late rupture, and complications (con-
version to open, proximal or distal extension cuff, angio-
plasty, or embolization).
Results: Our cohort comprised 9503 patients. Median
follow-up duration was 5.5 (interquartile range, 2.6-7.2)
years. Incomplete surveillance was observed in 54.7% of pa-
tients, and was observed at 3.26 1.7 years after EVAR. Pa-
tients with incomplete surveillance had lower all-cause
mortality (45.8% vs 68.2%, P < .001), fewer late ruptures
(0.8% vs 1.4%, P ¼ .003), and fewer complications (1.6%
vs 6.2%, P < .001). Aneurysm-related mortality was equiv-
alent (0.7%) for both groups and was not associated with
incomplete surveillance by multivariable logistic regression
(adjusted odds ratio, 0.95; 95% conﬁdence interval, 0.58-
1.55, P ¼ .8). Those with incomplete surveillance had
longer intervals from EVAR to late rupture (5.24 vs 3.48
years, P < .001), complications (4.10 vs 1.78 years, P <
.001), and all-cause mortality (5.20 vs 2.85 years, P <
.001). Incomplete surveillance was associated with a lower
total cost ($9353 6 $9774 vs $9948 6 $12,628,
P < .001) and lower cost per year ($1471 6 $1436 vs
$3043 6 $3222, P < .001).
Conclusions: Nonadherence to SVS guidelines for
post-EVAR imaging was not associated with poor out-
comes. Our ﬁndings suggest the need for improved criteria
for deﬁning optimal surveillance intervals to achieve desired
outcomes while reducing unnecessary cost and resource
utilization.
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Objectives: To evaluate renal artery (RA) and acces-
sory RA (ARA) anatomy and implications for endovascular
repair with fenestrated, branched, or parallel (chimney,
snorkel, and periscope) stent graft techniques.
